
Hannah Kuchler
Global Pharmaceuticals Correspondent at Financial Times
Global pharma editor @FT, leading science and pharma team. Emmy-nominated, Loeb winner. Previously NY, SF, HK. On parental leave, email [email protected].
Articles
-
1 day ago |
ft.com | Michael Peel |Hannah Kuchler
Novo Nordisk has agreed a partnership worth up to $2.2bn with US biotech Septerna, as the Danish drugmaker tries to shore up its pipeline...
-
2 days ago |
ft.com | Hannah Kuchler
Walking through the doors of the Arc mental health day centre, there is a noticeable absence.
-
1 week ago |
ft.com | Mercedes Ruehl |Hannah Kuchler
China has seized on geopolitical turmoil to present itself as stable and business friendly, according to one of the world’s largest...
-
2 weeks ago |
ft.com | Hannah Kuchler
GSK will use technologies including artificial intelligence to improve its productivity as a means of compensating for the potential...
-
2 weeks ago |
ft.com | Hannah Kuchler
The head of Zealand Pharma has called its $5.3bn partnership with Roche to commercialise an obesity drug with fewer side-effects the...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 19K
- Tweets
- 2K
- DMs Open
- Yes

RT @AnnaSophieGross: NEW: AstraZeneca has ditched plans to build new vaccine manufacturing plant in Merseyside, less than a year after it w…

Scoop: AstraZeneca ditches plans to invest in a vaccine manufacturing plant in Speke. With @AnnaSophieGross https://t.co/kg8kvJlzkV

RT @ClaerB: There are high hopes for #bonusseason in the City this year - but how does yours measure up? Early entries to the FT's Bonus Su…